Drug Shortage Report for LMD 10% IN DEXTROSE 5%
Report ID | 84660 |
Drug Identification Number | 00224235 |
Brand name | LMD 10% IN DEXTROSE 5% |
Common or Proper name | LMD 10 % in Dextrose 5% |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE DEXTRAN |
Strength(s) | 50MG 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 12 x 500mL PLBG |
ATC code | B05AA |
ATC description | BLOOD AND RELATED PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-05-24 |
Estimated end date | 2019-06-17 |
Actual end date | 2019-06-10 |
Shortage status | Resolved |
Updated date | 2019-06-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-05-24 | English | Compare |
v2 | 2019-05-24 | French | Compare |
v3 | 2019-05-25 | English | Compare |
v4 | 2019-05-30 | English | Compare |
v5 | 2019-05-30 | French | Compare |
v6 | 2019-06-11 | English | Compare |
v7 | 2019-06-11 | French | Compare |
Showing 1 to 7 of 7